Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040348 (8-Amino-1,3-bis-cyclopropylmethyl-3,7-dihydro-puri...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of cGMP hydrolysis by PDE 5A | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040371 (1,3-Bis-cyclopropylmethyl-7-(4-methoxy-benzyl)-8-[...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040346 (8-Amino-1,3-bis-cyclopropylmethyl-7-(4-methoxy-ben...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040348 (8-Amino-1,3-bis-cyclopropylmethyl-3,7-dihydro-puri...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040379 (CHEMBL423559 | N'-[1,3-Bis-cyclopropylmethyl-7-(4-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040354 (8-Amino-1,3-bis-cyclopropylmethyl-7-(3,4-dimethoxy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040356 (8-Amino-1,3-bis-cyclopropylmethyl-7-(4-methoxy-ben...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 440 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50020874 ((3-Chloro-phenyl)-(4-phenyl-phthalazin-1-yl)-amine...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of phosphodiesterase 5A | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040371 (1,3-Bis-cyclopropylmethyl-7-(4-methoxy-benzyl)-8-[...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 610 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040362 (8-Amino-7-benzyl-1,3-bis-cyclopropylmethyl-3,7-dih...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 840 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040372 (8-Amino-7-(4-chloro-benzenesulfonyl)-1,3-bis-cyclo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM14363 (3-(2-propoxyphenyl)-2,4,7,8,9-pentazabicyclo[4.3.0...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040377 (2-(2-Propoxy-phenyl)-1,7-dihydro-purin-6-one | 2-(...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of phosphodiesterase 5A | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040359 (CHEMBL145159 | N-[1,3-Bis-cyclopropylmethyl-7-(4-m...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040349 (8-Amino-1,3-bis-cyclopropylmethyl-7-(toluene-4-sul...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040345 (CHEMBL146165 | N-(1,3-Bis-cyclopropylmethyl-2,6-di...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040359 (CHEMBL145159 | N-[1,3-Bis-cyclopropylmethyl-7-(4-m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040351 (8-Amino-1,3-bis-cyclopropylmethyl-7-propyl-3,7-dih...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040355 (1,3-Bis(cyclopropylmethyl)-8-bis[(4-nitrophenylsul...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040344 (8-Amino-1,3-bis-cyclopropylmethyl-7-(propane-2-sul...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040362 (8-Amino-7-benzyl-1,3-bis-cyclopropylmethyl-3,7-dih...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040350 (8-Amino-1,3-bis-cyclopropylmethyl-7-methanesulfony...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040352 (1,3-Bis-cyclopropylmethyl-8-[1-methyl-pyrrolidin-(...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040343 (8-Amino-1,3-bis-cyclopropylmethyl-7-isobutyl-3,7-d...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040369 (8-Amino-7-benzenesulfonyl-1,3-bis-cyclopropylmethy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040349 (8-Amino-1,3-bis-cyclopropylmethyl-7-(toluene-4-sul...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 3.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040372 (8-Amino-7-(4-chloro-benzenesulfonyl)-1,3-bis-cyclo...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 4.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-dependent 3',5'-cyclic phosphodiesterase (Bos taurus) | BDBM50040375 (1,3-Bis(cyclopropylmethyl)-8-bis[(4-nitrophenylsul...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 5.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of phosphodiesterase 2 at 100 uM | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040376 (1,3-Bis(cyclopropylmethyl)-8-bis[(phenylsulfonyl)a...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 6.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040366 (8-Amino-1,3-bis-cyclopropylmethyl-7-(4-nitro-benzy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 8.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040365 (8-Amino-1,3-bis-cyclopropylmethyl-7-naphthalen-1-y...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 9.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM50040358 (5-(3-Cyclopentyloxy-4-methoxy-phenyl)-pyrrolidin-2...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040343 (8-Amino-1,3-bis-cyclopropylmethyl-7-isobutyl-3,7-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Homo sapiens (Human)) | BDBM14363 (3-(2-propoxyphenyl)-2,4,7,8,9-pentazabicyclo[4.3.0...) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of phosphodiesterase 1C at 100 uM | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040374 (8-Amino-1,3-bis-cyclopropylmethyl-7-(3,4,5-trimeth...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040351 (8-Amino-1,3-bis-cyclopropylmethyl-7-propyl-3,7-dih...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Rattus norvegicus (rat)) | BDBM10847 (1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dion...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | PubMed | n/a | n/a | 1.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of adenosine binding to A1 receptorof rat brain homogenates | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040368 (8-Amino-1,3-bis-cyclopropylmethyl-7-methyl-3,7-dih...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040363 (1,3-Bis(cyclopropylmethyl)-8-bis[(phenylsulfonyl)a...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040357 (CHEMBL358574 | N-(1,3-Bis-cyclopropylmethyl-2,6-di...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 2.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040355 (1,3-Bis(cyclopropylmethyl)-8-bis[(4-nitrophenylsul...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040350 (8-Amino-1,3-bis-cyclopropylmethyl-7-methanesulfony...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040375 (1,3-Bis(cyclopropylmethyl)-8-bis[(4-nitrophenylsul...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040347 (CHEMBL142922 | N-[1,3-Bis-cyclopropylmethyl-2,6-di...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 3.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040364 (8-Amino-1,3-bis-cyclopropylmethyl-7-(3-trifluorome...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 3.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040344 (8-Amino-1,3-bis-cyclopropylmethyl-7-(propane-2-sul...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 3.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040360 (8-Amino-1,3-bis-cyclopropylmethyl-7-(4-nitro-benze...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 3.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040367 (8-Amino-1,3-bis-cyclopropylmethyl-7-(2,5-dimethoxy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 4.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040353 (8-Amino-1,3-bis-cyclopropylmethyl-7-(4-trifluorome...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 4.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50040373 (CHEMBL344720 | N-(1,3-Bis-cyclopropylmethyl-7-meth...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 5.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Concentration required to inhibit 50% activity of phosphodiesterase VA isoenzyme at 100 microM. | J Med Chem 37: 476-85 (1994) BindingDB Entry DOI: 10.7270/Q2P26X6N | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 54 total ) | Next | Last >> |